Basic Information
Xell AG is a globally active biotechnology company focusing on the development, production, and sales of media and feed supplements for cell culture, especially for manufacturing viral vectors used in gene therapy and vaccine production. In addition to these media, the company also offers various analytical services for characterizing, screening, and quantifying medium components, as well as optimizing medium composition. Over a successful decade in the market, Xell has become an experienced and reliable partner in the biopharmaceutical industry, providing efficient off-the-shelf media and feed products, customized development, and dependable analytics.